Product pharmaceutical-intermediates-nuclide-drug

Home > products > pharmaceutical-intermediates> nuclide-drug

Catalog	name	Description	price
R-M2-9191	131I-Metuximab	The target of 131I-Metuximab/131Iodine-Metuximab is CEACAM8, which can be used for the treatment of hepatocellular carcinoma. Virtual price, please inquire if needed. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9192	131i-tositumomab	The target site of 131I tositumomab is CD20, which can be used for the treatment of refractory non Hodgkin lymphoma. Virtual price, please inquire if needed. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9193	90Y-ibritumomab tiuxetan	The target site of 90Y-ibritumomab tiuxetan is CD20, which can be used for the treatment of refractory non Hodgkin lymphoma. Virtual price, please inquire if needed. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9194	99mTc-besilesomab	The target of 99mTc-besilesomab is CEACAM8,which can be used for the diagnosis of osteomyelitis. Virtual price, please inquire if needed. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9195	17Lu-DOTATATE	17Lu-DOTATATE is a type of peptide receptor radionuclide therapy that for the treatment of somatostatin receptor-positive gastroenteropancreatic (GEP) neuroendocrine tumor (NET) patients. Virtual price, please inquire if needed. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9196	DOTATATE,cas177943-88-3	DOTATATE is a DOTA-conjugated peptide. DOTATATE can be labelled with radionuclides for positron emission tomography (PET) imaging and peptide receptor radionuclide research (PRRT).	price>
R-M2-9197	68Ga-DOTATATE	68Ga-DOTATATE/Gallium-68 DOTATATE/68Gallium-DOTATATE is emerging as the most sensitive and specific imaging agent. It can be used to diagnose a well-differentiated neuroendocrine tumor. Virtual price, please inquire if needed. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9198	177Lu-PCTA-NCS	Radionuclide177Lu is widely used in radiopharmaceuticals for cancer therapy.The 177Lu-PCTA-NCS complex could be obtained in high radiolabeling yields at ambient temperature and exhibited excellent stability in vitro. Virtual price, please inquire if needed. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9199	PCTA-NCS	PCTA-NCS is a bifunctional chelating agent.Virtual price, please inquire if needed.We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. Virtual price, please inquire if needed. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>
R-M2-9200	64Cu-177Lu-DOTATATE	64Cu-177Lu-DOTATATE is a theranostic radiopharmaceutical used in nuclear medicine for the diagnosis and treatment of neuroendocrine tumors (NETs). It combines the diagnostic properties of 64Cu and the therapeutic properties of 177Lu with the targeting molecule DOTATATE, which binds to somatostatin receptors commonly found on NET cells. This approach allows for both imaging and treatment of tumors, offering a personalized medicine option for patients with NETs. Virtual price, please inquire if needed. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.	price>

...